Arch-backed HC Bioscience closes doors after seeing early data for tRNA asset Arbor sails into rocky gene editing waters with $74M for rare liver disease therapy Sarepta reports 1 death after patient received DMD gene therapy Elevidys European VC shop Sofinnova closes €165M biotech acceleration fund with support from Amgen, BMS and Pfizer Vincerx, left in limbo by collapsed deal, moves to merge with AI company to escape cash crisis Pyxis lays off 20% of staff to swing behind single-candidate strategy Kiromic furloughs 'substantially all' workers amid cash crunch, leaving 31 staff without pay Flagship-backed Apriori Bio lays off employees, shifts focus to pipeline development Fierce Biotech Layoff Tracker 2025: Novartis plots 427 layoffs; Merck to cut 163 roles Nanobiotix tweaks J&J licensing deal for phase 3 cancer drug to eke out cash Avidity's latest DMD data drop assuages safety concerns for RNA-based asset: analyst | 